FDA Grants RMAT Designation to BrainChild Bio’s CAR-T Therapy for Deadly Pediatric Brain Tumors
The U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to BrainChild Bio for its B7-H3 CAR-T cell therapy. This experimental treatment targets aggressive brain tumors in children that currently have no cure. What Is CAR-T Therapy? CAR-T therapy is a form of immunotherapy. It involves modifying a patient’s T […]
Allogeneic Stem Cell Transplant: Everything You Need to Know
What is allogeneic stem cell transplant? This is a question that many people are asking these days. Allogeneic stem cell transplant is a treatment option for cancer patients. It involves the infusion of healthy stem cells into the patient’s body in order to fight cancer. In this article, we will discuss all aspects of allogeneic […]